Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transcriptional activator Klf5 recruits p300-mediated H3K27ac for maintaining trophoblast stem cell pluripotency. | J Mol Cell Biol | 2024 | 37533201 | PubTator, text mining | PubMed |
| PRMT5 activates KLF5 by methylation to facilitate lung cancer. | J Cell Mol Med | 2024 | 37461162 | PubTator, text mining | PubMed |
| Metabolic control of induced pluripotency. | Front Cell Dev Biol | 2023 | 38274274 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers. | Front Endocrinol (Lausanne) | 2023 | 38260135 | PubTator, text mining | PubMed |
| Transcription factor-target gene regulatory network analysis in human lung adenocarcinoma. | J Thorac Dis | 2023 | 38249888 | PubTator, text mining | PubMed |
| Long COVID: Molecular Mechanisms and Detection Techniques. | Int J Mol Sci | 2023 | 38203577 | PubTator, text mining | PubMed |
| Transcriptomics yields valuable information regarding the response mechanisms of Chinese Min pigs infected with PEDV. | Front Vet Sci | 2023 | 38192721 | PubTator, text mining | PubMed |
| Combining bioinformatics and machine learning algorithms to identify and analyze shared biomarkers and pathways in COVID-19 convalescence and diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 38169604 | PubTator, text mining | PubMed |
| Superfamily II helicases: the potential therapeutic target for cardiovascular diseases. | Front Cardiovasc Med | 2023 | 38152606 | PubTator, text mining | PubMed |
| The "StemDif Sensor Test": A Straightforward, Non-Invasive Assay to Characterize the Secreted Stemness and/or Differentiation Activities of Tumor-Derived Cancer Cell Lines. | Biomedicines | 2023 | 38137514 | PubTator, text mining | PubMed |
| PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma. | Cancers (Basel) | 2023 | 38136401 | PubTator, text mining | PubMed |
| The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges. | Mol Ther Oncolytics | 2023 | 38130701 | PubTator, text mining | PubMed |
| WWP1 E3 ligase at the crossroads of health and disease. | Cell Death Dis | 2023 | 38129384 | PubTator, text mining | PubMed |
| Shedding light on the dark genome: Insights into the genetic, CRISPR-based, and pharmacological dependencies of human cancers and disease aggressiveness. | PLoS One | 2023 | 38117798 | PubTator, text mining | PubMed |
| The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review. | BMC Cancer | 2023 | 38110859 | PubTator, text mining | PubMed |
| The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer. | Cell Death Discov | 2023 | 38104139 | PubTator, text mining | PubMed |
| KLF5 promotes esophageal squamous cell cancer through the transcriptional activation of FGFBP1. | Med Oncol | 2023 | 38087142 | PubTator, text mining | PubMed |
| The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers. | Mol Biol Rep | 2023 | 38085375 | PubTator, text mining | PubMed |
| Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells. | Nat Commun | 2023 | 38081833 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=17